UC San Diego Health Sciences News

  • Archive
  • RSS
  • Questions about our posts?
Image courtesy of Dan Anderson www.danandersonphoto.com
Using Biomarkers to Identify and Treat SchizophreniaResearchers say lab-based tests may be boon to both clinicians and researchers
In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.
“A major problem in psychiatry is that there are currently no laboratory tests that aid in diagnosis, guide treatment decisions or help predict treatment response or outcomes,” said Gregory A. Light, PhD, associate professor of psychiatry and the study’s first author. “Diagnoses are currently based on a clinician’s ability to make inferences about patients’ inner experiences.”
Diagnosing and treating schizophrenia is a particularly troubling challenge. The disorder, which affects about 1 percent of the U.S. population or roughly 3 million people, is characterized by a breakdown of normal thought processes and erratic, sometimes dangerous or harmful, behaviors.
“Schizophrenia is among the most severe and disabling conditions across all categories of medicine,” said Light, who also directs the Mental Illness, Research, Education and Clinical Center at the San Diego VA Healthcare System.
The precise cause or causes of schizophrenia are not known, though there is a clear genetic component, with the disorder more common in some families.
Clinicians typically diagnose schizophrenia based upon inferences drawn from the patient’s inner experiences. That is, their ability to describe what’s happening inside their minds.
More here
Pop-upView Separately

Image courtesy of Dan Anderson www.danandersonphoto.com

Using Biomarkers to Identify and Treat Schizophrenia
Researchers say lab-based tests may be boon to both clinicians and researchers

In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.

“A major problem in psychiatry is that there are currently no laboratory tests that aid in diagnosis, guide treatment decisions or help predict treatment response or outcomes,” said Gregory A. Light, PhD, associate professor of psychiatry and the study’s first author. “Diagnoses are currently based on a clinician’s ability to make inferences about patients’ inner experiences.”

Diagnosing and treating schizophrenia is a particularly troubling challenge. The disorder, which affects about 1 percent of the U.S. population or roughly 3 million people, is characterized by a breakdown of normal thought processes and erratic, sometimes dangerous or harmful, behaviors.

“Schizophrenia is among the most severe and disabling conditions across all categories of medicine,” said Light, who also directs the Mental Illness, Research, Education and Clinical Center at the San Diego VA Healthcare System.

The precise cause or causes of schizophrenia are not known, though there is a clear genetic component, with the disorder more common in some families.

Clinicians typically diagnose schizophrenia based upon inferences drawn from the patient’s inner experiences. That is, their ability to describe what’s happening inside their minds.

More here

    • #Schizophrenia
    • #Psychiatry
    • #Neuroscience
    • #Biomarkers
    • #Endophenotypes
  • 10 months ago
  • 28
  • Permalink
  • Share
    Tweet

28 Notes/ Hide

  1. ryuusukelikes reblogged this from ucsdhealthsciences
  2. ryuusukenotameiki likes this
  3. jackiengo likes this
  4. cornucopiaofscience reblogged this from ucsdhealthsciences
  5. supernovajamie likes this
  6. m0lestia reblogged this from ucsdhealthsciences
  7. m0lestia likes this
  8. catapps reblogged this from ucsdhealthsciences
  9. phillipelinhares likes this
  10. puspitadewi17 reblogged this from ucsdhealthsciences
  11. victorianavina-medicine reblogged this from ucsdhealthsciences
  12. quimmanaheim likes this
  13. master-net likes this
  14. inspireme923 reblogged this from ucsdhealthsciences
  15. catty1 likes this
  16. timeneverenoughtime reblogged this from s-cientia
  17. readinglist32 reblogged this from ucsdhealthsciences
  18. readinglist32 likes this
  19. so-will-we likes this
  20. 12342594 likes this
  21. charmainegrace reblogged this from ucsdhealthsciences
  22. charmainegrace likes this
  23. s-cientia reblogged this from ucsdhealthsciences
  24. lemarcusray likes this
  25. painedbrain likes this
  26. roxandroid likes this
  27. jetstreamsams reblogged this from ucsdhealthsciences
  28. thescienceofreality likes this
  29. ucsdhealthsciences posted this
← Previous • Next →

Logo

News from UC San Diego Health Sciences
Media Contacts: 619-543-6163
HealthSciComm@ucsd.edu

UC San Diego, Elsewhere

  • @UCSDHealth on Twitter
  • Facebook Profile
  • UCSDMedicalCenter on Youtube
  • Google
  • Linkedin Profile

Following

  • RSS
  • Random
  • Archive
  • Questions about our posts?
  • Mobile

Effector Theme by Carlo Franco.

Powered by Tumblr